I've given your post a like, as I agree that it is always...

I've given your post a like, as I agree that it is always better to have directors with skin in the game than not (or small holdings). Saying that, I don't think it is related to the current SP malaise.

While not a member of the Board, Rhythm's company secretary, Adrien Wing (through his wife) remains the largest shareholder with 11,000,000 shares (as of August 2019). Adrien, along with Richard Vom (Loumea Investments 10,000,000 shares) are the architects who put RHY together as a company. Their combined holdings are close to 20% of the company's total equity. And they don't seem to have sold a single share since RHY's inception. With that kind of control, it would be simple to pressure/influence management.

In fact, reaching out to either of them is a future option I will explore - if I feel that management are treating this as a lifestyle company, rather than working hard to create SH value. While frustrated, I have not reached that point as yet. I am still backing Glenn & Co in to nail the trials & prove that the science is robust & that they can & will commercialise ColoSTAT.